$ARNA Belviq TRx for week of 6/14 (per IMS) --> 1,087To put this into context, Belviq was only available three days to reach 1,087 prescriptions. It took Qsymia three weeks to get to 1,000 prescriptions. Shares of ARNA are gapping up this morning as a result. Shorts hoping for an unsuccessful Belviq commercial launch better cover now, because they are in for a rude awakening.
— Adam Feuerstein (@adamfeuerstein) June 21, 2013
You know the tide is turning when Arena's former biggest basher has to report positive results.
No comments:
Post a Comment